Boston Scientific Corporation
USD122.18
+2.83 (+2.37%)
CEO
Michael F. Mahoney
IPO Date
2020-05-22
Sector
Healthcare
Industry
Medical - Devices
Exchange
NYSE
Country
US
Open
$119.70
Prev. Close
$119.35
Day Low
$119.70
Day High
$123.27
52W Low
$97.37
52W High
$129.12
Market Cap
$175.45B
Volume
2.06M
| 70.9 |
| 31 Dec 2023 | FY | 62.0% | 11.2% | 8.3% | 4.5% | 0.49 | 1.32 | 52.7 |
| 31 Dec 2022 | FY | 60.8% | 5.5% | 4.0% | 2.1% | 0.53 | 1.51 | 94.8 |
| 31 Dec 2021 | FY | 62.8% | 8.7% | 6.3% | 3.2% | 0.57 | 1.48 | 58.1 |
| 31 Dec 2020 | FY | 56.2% | -0.8% | -0.5% | -0.3% | 0.62 | 1.82 | -621.1 |
| 31 Dec 2019 | FY | 64.1% | 43.8% | 33.9% | 15.4% | 0.74 | 0.97 | 13.4 |
| 31 Dec 2018 | FY | 65.9% | 17.0% | 19.2% | 8.0% | 0.81 | 0.76 | 29.2 |
| 31 Dec 2017 | FY | 64.9% | 1.1% | 1.5% | 0.5% | 0.80 | 0.68 | 326.6 |
| 31 Dec 2016 | FY | 63.7% | 4.1% | 5.2% | 1.9% | 0.81 | 0.90 | 84.6 |
| 52.9 |
| 30 Sept 2025 | Q3 | 69.9% | 14.9% | 3.2% | 1.8% | 0.51 | 1.51 | 47.9 |
| 30 Jun 2025 | Q2 | 67.7% | 15.7% | 3.5% | 1.9% | 0.54 | 1.37 | 50.1 |
| 31 Mar 2025 | Q1 | 63.3% | 14.5% | 3.0% | 1.7% | 0.53 | 1.45 | 55.3 |
| 31 Dec 2024 | Q4 | 58.6% | 12.4% | 2.6% | 1.4% | 0.51 | 1.08 | 58.2 |
| 30 Sept 2024 | Q3 | 62.9% | 11.1% | 2.3% | 1.2% | 0.54 | 1.48 | 65.8 |
| 30 Jun 2024 | Q2 | 62.7% | 7.9% | 1.6% | 0.9% | 0.54 | 1.61 | 86.7 |
| 31 Mar 2024 | Q1 | 61.8% | 12.8% | 2.5% | 1.3% | 0.55 | 1.66 | 50.6 |
| 31 Dec 2023 | Q4 | 62.1% | 13.5% | 2.6% | 1.4% | 0.49 | 1.32 | 42.0 |